KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 83 filers reported holding KEROS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $81,645 | -27.9% | 2,561 | -9.1% | 0.05% | -25.4% |
Q2 2023 | $113,227 | +31.5% | 2,818 | +39.7% | 0.07% | +42.6% |
Q1 2023 | $86,126 | -35.7% | 2,017 | -27.7% | 0.05% | -32.9% |
Q4 2022 | $133,880 | -7.0% | 2,788 | -27.1% | 0.07% | +22.8% |
Q3 2022 | $144,000 | +37.1% | 3,825 | +0.8% | 0.06% | +46.2% |
Q2 2022 | $105,000 | -40.0% | 3,793 | +17.6% | 0.04% | -50.0% |
Q1 2022 | $175,000 | -12.5% | 3,225 | -5.6% | 0.08% | +2.6% |
Q4 2021 | $200,000 | +25.8% | 3,416 | -14.9% | 0.08% | +8.6% |
Q3 2021 | $159,000 | -11.7% | 4,016 | -5.0% | 0.07% | -5.4% |
Q2 2021 | $180,000 | -23.7% | 4,229 | +10.3% | 0.07% | -26.0% |
Q1 2021 | $236,000 | -10.9% | 3,835 | +2.0% | 0.10% | -9.1% |
Q4 2020 | $265,000 | – | 3,758 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,382,641 | $85,102,000 | 10.19% |
Consonance Capital Management LP | 890,209 | $54,792,000 | 5.84% |
CHI Advisors LLC | 400,468 | $24,649,000 | 4.94% |
Fairmount Funds Management LLC | 109,333 | $6,729,000 | 2.84% |
VR Adviser, LLC | 372,306 | $22,915,000 | 2.49% |
Opaleye Management Inc. | 157,500 | $9,694,000 | 1.42% |
Darwin Global Management, Ltd. | 86,887 | $5,348,000 | 1.05% |
Orbimed Advisors | 1,679,417 | $103,368,000 | 0.97% |
Nantahala Capital Management | 460,372 | $28,336,000 | 0.83% |
Eventide Asset Management | 427,414 | $26,307,000 | 0.39% |